Your browser is no longer supported. Please, upgrade your browser.
AMRN Amarin Corporation plc daily Stock Chart
Amarin Corporation plc
Index- P/E- EPS (ttm)-0.27 Insider Own0.80% Shs Outstand359.33M Perf Week0.78%
Market Cap6.05B Forward P/E195.81 EPS next Y0.09 Insider Trans0.00% Shs Float175.42M Perf Month4.92%
Income-84.40M PEG- EPS next Q-0.04 Inst Own48.80% Short Float26.86% Perf Quarter-11.42%
Sales306.70M P/S19.73 EPS this Y-75.40% Inst Trans8.67% Short Ratio5.19 Perf Half Y-3.83%
Book/sh0.38 P/B44.32 EPS next Y147.40% ROA-24.90% Target Price31.71 Perf Year490.88%
Cash/sh0.62 P/C27.28 EPS next 5Y24.70% ROE-111.80% 52W Range2.78 - 23.91 Perf YTD23.73%
Dividend- P/FCF- EPS past 5Y17.60% ROI-51.40% 52W High-29.57% Beta1.11
Dividend %- Quick Ratio1.80 Sales past 5Y54.10% Gross Margin76.90% 52W Low506.85% ATR0.71
Employees530 Current Ratio2.00 Sales Q/Q91.60% Oper. Margin-25.90% RSI (14)53.45 Volatility3.35% 4.77%
OptionableYes Debt/Eq0.54 EPS Q/Q95.30% Profit Margin-27.50% Rel Volume0.54 Prev Close16.94
ShortableYes LT Debt/Eq0.18 EarningsOct 30 BMO Payout- Avg Volume9.08M Price16.84
Recom1.40 SMA205.29% SMA50-1.01% SMA200-5.17% Volume4,873,783 Change-0.59%
Aug-14-19Initiated SVB Leerink Outperform $26
Jul-09-19Reiterated Jefferies Buy $30
Jun-17-19Initiated ROTH Capital Buy $31
Mar-22-19Initiated Stifel Buy $27
Nov-14-18Upgrade Citigroup Neutral → Buy
Nov-02-18Downgrade Citigroup Buy → Neutral
Jun-27-17Resumed Cantor Fitzgerald Overweight
Oct-19-16Initiated Citigroup Buy $5
Oct-05-16Initiated Cantor Fitzgerald Buy $6
May-12-16Resumed Jefferies Buy
Mar-12-15Upgrade H.C. Wainwright Neutral → Buy $2.50 → $10
Apr-01-14Reiterated MKM Partners Neutral $1.50 → $2
Feb-24-14Reiterated MKM Partners Neutral $2.50 → $1.75
Jan-16-14Downgrade MKM Partners Buy → Neutral $2.50
Nov-08-13Reiterated MKM Partners Buy $5 → $2.50
Oct-30-13Initiated FBR Capital Mkt Perform $2
Oct-17-13Reiterated MKM Partners Buy $9 → $5
Oct-17-13Downgrade Canaccord Genuity Buy → Hold $10 → $3
Oct-17-13Downgrade Aegis Capital Buy → Hold
Mar-20-13Initiated Chardan Capital Markets Hold $8.50
Sep-17-19 10:11AM  2 Small Biotech Stocks Just Made Citis Top 5 List
Sep-16-19 06:00AM  National Lipid Associations New Position Statement on Use of Icosapent Ethyl in High and Very-High-Risk Patients Recognizes Importance of Addressing Residual Cardiovascular Risk in Patients on Statins GlobeNewswire
Sep-09-19 10:35AM  Amarin: Keep Your Dry Powder Ready Motley Fool
Sep-05-19 10:12AM  3 Strong Buy Biotech Stocks Ahead of FDA Verdicts SmarterAnalyst
Sep-03-19 06:00AM  New 2019 Updates to the European Society of Cardiologys and European Atherosclerosis Societys Guidelines for the Management of Dyslipidaemias Incorporate Findings from the REDUCE-IT Cardiovascular Outcomes Study GlobeNewswire
Aug-28-19 01:26PM  Vascepa Is Safe and Should Be Approved by End of Year, Amarin CEO Says Bloomberg
06:00AM  Amarin to Participate in the H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire
Aug-27-19 11:43AM  Is Amarin Corporation plc's (NASDAQ:AMRN) CEO Being Overpaid? Simply Wall St.
06:00AM  Amarin Provides Overview on Growing Global Attention on REDUCE-IT Results and Cardiovascular Risk Management Beyond Cholesterol Management GlobeNewswire
Aug-26-19 04:11AM  Why Strong Buy Amarin Can Double, Say Top Analysts TipRanks
Aug-22-19 01:31PM  3 Top Healthcare Stocks to Buy Right Now Motley Fool
Aug-21-19 06:00AM  Amarin to Participate in a Fireside Chat at Citis 14th Annual Biotech Conference GlobeNewswire
Aug-20-19 01:06PM  8 Biotech Stocks to Watch After the Q2 Earnings Season InvestorPlace
Aug-18-19 07:37AM  3 Healthcare Stocks to Fight Off the Market Flu TipRanks
Aug-17-19 11:04AM  Better Buy: GW Pharmaceuticals vs. Amarin Motley Fool
Aug-15-19 12:27PM  Another Day, Another Buy Rating for Amarin (AMRN) Stock TipRanks
Aug-14-19 11:31AM  Amarin Shares Show Heart as Anti-Cholesterol Drug Firm Bucks Market Rout
09:21AM  Biotech Stock Roundup: Amgen's Enbrel Patent Win, AMRN's Setback & More Zacks
Aug-12-19 06:05PM  Dont Say Bye Bye to Amarin (AMRN) Stock, Say Buy Buy TipRanks -5.96%
Aug-09-19 03:13PM  Pharma companies Amarin, Nektar Therapeutics nosedive on product concerns Yahoo Finance Video -17.07%
03:04PM  How the 10 Best Stocks From Last Year Hold Up Today InvestorPlace
01:50PM  Why Amarin Stock Is Tanking Today Motley Fool
01:33PM  Drugmakers Put Bad Spin on a Bizarre Week Bloomberg
11:39AM  Biotech Investors Jolted Out of Summer Lull as High-Fliers Sink Bloomberg
10:52AM  Amarin Shares Topple On Adcom Meeting Surprise For Fish Oil Pill Benzinga
08:53AM  Amarin (AMRN) Alert: Johnson Fistel Launches Investigation into Amarin Corporation plc; Investors Encouraged to Contact Firm PR Newswire
07:19AM  The Daily Biotech Pulse: Vascepa Delay Sends Amarin Reeling, Eidos Jumps On Buyout Offer, Nektar's Bitter Q2 Benzinga
06:49AM  [video]Amarin Dives on Surprise FDA Heart-Drug Review
Aug-08-19 04:30PM  Amarin Announces FDA Notification of Advisory Committee Meeting Planned to be Held in November 2019 in Connection With Vascepa® REDUCE-IT sNDA GlobeNewswire +5.63%
Aug-06-19 03:40PM  Biotech Stocks to Watch Through the 2nd Half of 2019
Aug-05-19 01:14PM  Edited Transcript of AMRN earnings conference call or presentation 31-Jul-19 11:30am GMT Thomson Reuters StreetEvents
Jul-31-19 03:00PM  What You'll Want to Know About Amarin's Strong Q2 Results Motley Fool
01:23PM  Amarin Corporation plc (AMRN) Q2 2019 Earnings Call Transcript Motley Fool
10:30AM  3 Takeaways From Amarin's Earnings Motley Fool
07:56AM  Amarin (AMRN) Beats Earnings & Beats Revenues in Q2 Zacks
07:06AM  The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster Benzinga
05:00AM  Amarin Reports Second Quarter 2019 Financial Results and Operational Update GlobeNewswire
Jul-30-19 02:13PM  A Preview Of Amarin's Q2 Earnings Benzinga
Jul-26-19 11:50AM  What's in the Cards for Amarin (AMRN) This Earnings Season? Zacks
Jul-24-19 11:18AM  Amarin Is Just Running Up That Hill; Peak Sales Could Reach $10B, Says Analyst TipRanks
06:00AM  Amarin to Report Second Quarter 2019 Results and Host Conference Call on July 31, 2019 GlobeNewswire
Jul-21-19 01:53PM  Amarin: Is a Buyout Really Off the Table? Motley Fool
Jul-20-19 08:00AM  IBD Stock Of The Day: Winners, Losers And This FANG Stock Investor's Business Daily
Jul-19-19 12:39PM  A Look At Benzinga Pro's Most-Searched Tickers For July 19, 2019 Benzinga
Jul-18-19 11:47PM  Amarin Prices Public Offering of American Depositary Shares GlobeNewswire -10.30%
04:33PM  Why United Rentals, Eagle Bancorp, and Amarin Slumped Today Motley Fool
01:47PM  Here's Why Amarin Stock Tumbled Today Motley Fool
Jul-17-19 04:01PM  Amarin Announces $400,000,000 Public Offering of American Depositary Shares GlobeNewswire
Jul-15-19 10:17AM  2 Incredibly Cheap Biotech Stocks to Buy Now Motley Fool
Jul-12-19 04:36PM  Soaring Amarin Stock Netted Quick Swing Trading Profit Investor's Business Daily
Jul-11-19 01:07PM  Amarin (NASDAQ:AMRN) Shareholders Have Enjoyed A Magnificent 1356% Share Price Gain Simply Wall St.
Jul-10-19 08:03AM  Why Amarin Stock Is Up 63% So Far in 2019 Motley Fool
Jul-09-19 11:40AM  Amarin Thinks Sales of Its Cardio Drug Could Be in the Billions
08:39AM  Implied Volatility Surging for Amarin (AMRN) Stock Options Zacks
Jul-07-19 07:45AM  3 Hot Biotechs Trending Now TipRanks
Jul-03-19 10:22AM  Amarin (AMRN) Issues Update on Q2 Sales, Raises '19 Guidance Zacks
09:39AM  Company News for Jul 3, 2019 Zacks
07:58AM  3 Big Stock Charts for Wednesday: CVS Health, Pfizer and Weyerhaeuser InvestorPlace
Jul-02-19 04:33PM  This IBD Stock Of The Day Expects An FDA Approval To Send Sales Flying Investor's Business Daily +16.27%
04:32PM  Why Maxar Technologies, Amarin, and Revolve Group Jumped Today Motley Fool
04:28PM  S&P 500 sets fresh high as 10-year Treasury yield slides to new two-year low MarketWatch
04:08PM  Here's Why Amarin Rose as Much as 16.3% Today Motley Fool
04:06PM  S&P 500 sets all-time high even as global growth concerns cap gains MarketWatch
04:04PM  5 Top Stock Trades for Wednesday: NKE, AMRN, GS InvestorPlace
01:34PM  Amarin Surges After Drugmaker Says Heart Pill Sales Are Booming Bloomberg
12:48PM  Amarin News: Why AMRN Stock Is Soaring Today InvestorPlace
10:49AM  Stocks Mixed Following Trade Adviser's Optimism on U.S.-China Pact
09:40AM  Amarin Surges on Revenue Guidance Boost
06:47AM  Amarin's stock surges after raised revenue outlook, increased commercial expansion of Vascepa MarketWatch
06:00AM  Amarin Provides Mid-2019 Update, Including Commercialization Plans for Vascepa® and Updates Full Year 2019 Revenue Guidance GlobeNewswire
Jun-29-19 08:09AM  2 Stocks That Could Be the Next Biotech Buyouts Motley Fool
Jun-25-19 11:09AM  8 Stocks May Jump on Takeovers as Market Nears Peak Investopedia
Jun-21-19 01:39PM  Amarins John Thero Awarded NJ EY Entrepreneur of The Year® 2019 Award for Life Sciences GlobeNewswire
Jun-19-19 08:11PM  Hedge Funds Have Never Been This Bullish On Amarin Corporation plc (AMRN) Insider Monkey
Jun-18-19 07:00AM  Amarin to Present at the 2019 BMO Prescription For Success Healthcare Conference GlobeNewswire
Jun-17-19 10:26PM  Amarin Stock Poised for Even More Gains Investopedia
Jun-07-19 07:12AM  Amarin to Present Findings Regarding Challenges of Current Treatment Options in Reducing Cardiovascular Risks for Diabetes Patients, Even for Those With Controlled Cholesterol Levels, at Annual American Diabetes Association (ADA) Meeting GlobeNewswire
Jun-04-19 02:10PM  Amarin Corporation plc (NASDAQ:AMRN): When Will It Breakeven? Simply Wall St.
06:00AM  Amarin to Present at the Goldman Sachs 40th Annual Global Healthcare Conference GlobeNewswire
May-30-19 04:03PM  5 Top Stock Trades for Friday: AAPL, VEEV, DG, DLTR InvestorPlace
08:28AM  Amarin Rises on Priority Review for Vascepa Label Expansion Zacks
07:31AM  3 Top Mid-Cap Stocks to Buy Right Now Motley Fool
07:00AM  Pharmaceutical Industry Veteran Gwen Fisher Joins Amarin to Lead Corporate Communications GlobeNewswire
May-29-19 11:44PM  This Biotech Stock Rocketed Near A Buy Point On Speedy Drug Review Investor's Business Daily +11.64%
04:32PM  Why Cypress Semiconductor, Amarin, and Heico Jumped Today Motley Fool
02:12PM  Amarin shares soar after FDA agrees to fast-track review of its prescription strength fish oil pill for heart patients CNBC
01:04PM  Bulls shop at this discount retailer CNBC Videos
11:58AM  Here's Why Amarin Soared Today Motley Fool
10:37AM  Amarin's Cardiovascular Fish Oil Pill May Hit Market Sooner: FDA Accords Priority Review Designation Benzinga
06:00AM  U.S. FDA Grants Priority Review for Vascepa® (Icosapent Ethyl) Supplemental New Drug Application Seeking Cardiovascular Risk Reduction Indication GlobeNewswire
May-24-19 01:20PM  Options traders say it's hip to be Square CNBC Videos
May-16-19 04:15PM  Vascepa® to Be Featured in Multiple Scientific Sessions at the National Lipid Association Annual Meeting GlobeNewswire
May-07-19 10:10AM  Edited Transcript of AMRN earnings conference call or presentation 1-May-19 11:30am GMT Thomson Reuters StreetEvents
May-06-19 10:16AM  Why Did Amarin (AMRN) Stock Sink After Earnings? Analysts Explain SmarterAnalyst
May-02-19 02:18PM  5 Biotech Stocks With Near-Term Catalysts Ahead Benzinga
01:21PM  These 6 biotech stocks are promising takeover targets MarketWatch
09:34AM  Options Traders Expect Huge Moves in Amarin (AMRN) Stock Zacks
08:33AM  Why Amarin's Stock Sank on Strong First-Quarter Results Motley Fool
May-01-19 03:00PM  Here's What You Need to Know From Amarin's Q1 Earnings Update Motley Fool -6.31%
11:54AM  Amarin Corporation plc (AMRN) Q1 2019 Earnings Call Transcript Motley Fool
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. Amarin Corporation plc sells its products principally to wholesalers and specialty pharmacy providers through direct sales force. It has a collaboration with Mochida Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., Biologix FZCo, and HLS Therapeutics, Inc. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.